Legislative sessions across the U.S. have got off to a lively start this year, with dozens of new psychedelics-related bills introduced and several efforts from the previous year reignited as legislatures reconvened.
Ibogaine research programs and multi-state consortia efforts are featuring prominently in the flurry of bills introduced this month, with an ibogaine research bill making a swift passage through the Mississippi House in a near-unanimous vote. Elsewhere, psilocybin rescheduling trigger ...
